Atopic dermatitis (AD) is a chronic inflammatory skin disease; its diagnosis is made by a combination of clinical features. AD is characterized by recurrent intense pruritus and a typically age-related distribution and skin morphology [1, 2]. The role of allergy in eliciting and maintaining the eczematous skin lesions has been controversial, partially due to the lack of specificity of the classic tests for IgE-mediated hypersensitivity. On the other hand, the most recent encouraging results of specific immunotherapy studies in AD patients with IgE-mediated allergies represent another line of evidence for the role of aeroallergens in AD. Among the allergens found to be relevant in AD, aeroallergens and food allergens (in children) are most important. As therapeutical consequences of the diagnosis of an allergy are based upon avoidance strategies, the relevance of (often multiple) IgE-mediated sensitizations in patients with AD must be evaluated.
Environmental substances such as aeroallergens produce flares in some patients with AD. Also, aeroallergen avoidance, especially with regard to house dust mites, can result in marked improvement of skin lesions [3]. Patients with AD often have elevated serum levels of IgE, which may correlate with the disease severity. The hypothesis is that Langerhans’ cells bind and present “immediate type” allergens [4], which penetrate the impaired epidermal barrier in AD patients [5]. This concept is derived from studies showing IgE and IgE-binding structures on the surface of epidermal Langerhans’ cells [5] together with mite allergen [6]. From atopy patch test biopsies, allergen-specific T cells have been cloned [7]. These T cells showed a characteristic TH2 (T-helper cell subpopulation) secretion pattern initially, while after 48 h a TH1 pattern was predominant. This same pattern is also found in chronic lesions of AD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Rajka G (1989) Essential aspects of atopic dermatitis. Springer, Berlin
Ring J (1991) Angewandte Allergologie, 2. Aufl. MMV Medizin Verlag, München
Tan B, Weald D, Strickland I, Friedman P (1996) Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet 347:15–18
Maurer D, Ebner C, Reininger B, Fiebiger E, Kraft D, Kinet JP, Stingl G (1995) The high affinity IgE receptor mediates IgE-dependent allergen presentation. J Immunol 154:6285–6290
Bieber T (1994) FCeRI on human Langerhans cells: a receptor in search of new functions. Immunol Today 15:52–53
Tanaka Y, Anan S, Yoshida H (1990) Immunohistochemical studies in mite antigen-induced patch test sites in atopic dermatitis. J Derm Science 1:361–368
van Reijsen FC, Bruijnzeel-Koomen CAFM, Kalthoff FS, Maggi E, Romagnani S, Westland JKT, Mudde GC (1992) Skin-derived aeroallergen-specific T-cell clones of TH2 phenotype in patiens with atopic dermatitis. J Allergy Clin Immunol 90:184–192
Mitchell E, Chapman M, Pope F, Crow J, Jouhal S, Platts-Mills T (1982) Basophils in allergen-induced patch test sites in atopic dermatitis. Lancet 1:127–130
Darsow U, Vieluf D, Berg B, Berger J, Busse A, Czech W, Heese A, Heidelbach U, Peters KP, Przybilla B, Richter G, Rueff F, Werfel T, Wistokat-Wülfing A, Ring J (1999) Dose response study of atopy patch test in children with atopic eczema. Pediatr Asthma Allergy Immunol 13:115–122
Darsow U, Vieluf D, Ring J (1995) Atopy patch test with different vehicles and allergen concentrations – an approach to standardization. J Allergy Clin Immunol 95:677–684
Darsow U, Vieluf D, Ring J (1996) The atopy patch test: an increased rate of reactivity in patients who have an air-exposed pattern of atopic eczema. Br J Dermatol 135:182–186
Darsow U, Vieluf D, Ring J for the APT study group (1999) Evaluating the relevance of aeroallergen sensitization in atopic eczema using the tool “atopy patch test”: a randomized, double-blind multicenter study. J Am Acad Dermatol 40:187–193
Darsow U, Behrendt H, Ring J. (1997) Gramineae pollen as trigger factors of atopic eczema: evaluation of diagnostic measures using the atopy patch test. Br J Dermatol 137:201–207
Darsow U, Laifaoui J, Bolhaar S, Bruijnzeel-Koomen CAFM, Breuer K, Wulf A, Werfel T, Brönnimann M, Braathen LR, Dangoisse C, Blondeel A, Song M, Didierlaurent A, André C, Drzimalla K, Simon D, Disch R, Borelli S, Elst L, Devilliers A, Oranje AP, de Raeve L, Reiser K, Wollenberg A, Przybilla B, Roul S, Taieb A, Seidenari S, Wüthrich B, Ring J (2004) Atopy patch test with aeroallergens and food allergens in petrolatum: a European multicenter study. Allergy 59:1318–1325
Turjanmaa K, Darsow U, Niggemann B, Rancé F, Vanto T, Werfel T (2006) EAACI/GA2LEN position paper: present status of the atopy patch test – position paper of the section on dermatology and the section on pediatrics of the EAACI. Allergy 61:1377–1384
Weissenbacher S, Traidl-Hoffmann C, Eyerich K, Katzer K, Bräutigam M, Loeffler H, Hofmann H, Behrendt H, Ring J, Darsow U (2006) Modulation of atopy patch test and skin prick test by pretreatment with 1% pimecrolimus cream. Int Arch Allergy Immunol 140:239–244
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Darsow, U., Ring, J. (2009). The Atopy Patch Test in Atopic Dermatitis. In: Patch Testing and Prick Testing. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-92806-5_9
Download citation
DOI: https://doi.org/10.1007/978-3-540-92806-5_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-92805-8
Online ISBN: 978-3-540-92806-5
eBook Packages: MedicineMedicine (R0)